<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lederman, Lynne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">DeFronzo, Ralph A.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">SCALE Diabetes: Continually Dosed Liraglutide May Aid Weight Loss in T2DM</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">20-21</style></pages><abstract><style  face="normal" font="default" size="100%">This article presents the results of the Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes trial [SCALE Diabetes; NCT01272232]. This large, multicenter, international trial investigated the efficacy and safety of 56 weeks of treatment with 2 doses of liraglutide, 3.0 and 1.8 mg, compared with placebo, as an adjunct to diet and exercise in inducing and maintaining weight loss in overweight or obese individuals with type 2 diabetes mellitus (T2DM).</style></abstract><number><style face="normal" font="default" size="100%">32</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>